ROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsight
DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...
Eyenovia Shares Drop 14% Amid Betaliq Merger Talks
Combining Eyenovia's Optejet dispensing system with Betaliq's EyeSol medication delivery mechanism, the purchase would create ...
Finanznachrichten13d
Eyenovia, Inc.: Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol ® water-free drug delivery technology for glaucoma with Eyenovia's Optejet ® device platform ...
Eyenovia falls on plans to seek reverse merger
Eyenovia (EYEN) stock falls as the company plans a reverse merger with Betaliq, to create an ophthalmology focused drugmaker. Read more here.
Eyenovia enters non-binding LOI to effect reverse merger with Betaliq
Eyenovia (EYEN), has entered into a non-binding letter of intent contemplating a potential reverse merger transaction with Betaliq, a clinical ...
Eyenovia Plans All-Stock Reverse Merger With Betaliq
Eyenovia on Thursday said it has signed a non-binding letter of intent to combine with clinical-stage pharmaceutical company Betaliq in an all-stock reverse merger. Eyenovia said Betaliq investors ...
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform ...
Mena FN14d
Eyenovia Enters Into Non-Binding Letter Of Intent To Effect Reverse Merger With Betaliq
(MENAFN- GlobeNewsWire - Nasdaq) Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol ® water-free drug delivery technology for glaucoma with ...